We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The Food and Drug Administration said Monday it approved a new warning on Allergan Inc.'s (AGN) Botox and a similar product about the possibility of life-threatening breathing and swallowing...
The U.S. Food and Drug Administration said Thursday it was strengthening warnings on Allergan Inc.'s (AGN) Botox and similar products about the possibility of life-threatening breathing and...
The U.S. Food and Drug Administration said Thursday it was strengthening warnings on Allergan Inc.'s (AGN) Botox and similar products about the possibility of life-threatening breathing and...
Medicis Pharmaceutical Corp. (MRX) and Teva Pharmaceutical Industries Ltd. (TEVA) late Wednesday said they have agreed to halt all legal disputes between them over Medicis' Solodyn Extended...
RNS Number:0657U Metalrax Group PLC 09 January 2004 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company METALRAX GROUP PLC 2. Name of...
RNS Number:0275U Metalrax Group PLC 08 January 2004 Metalrax Group plc (the "Company") Director Shareholding The Company has today been informed that the following Director has changed...
RNS Number:8580T Metalrax Group PLC 05 January 2004 Metalrax Group plc (the "Company") Directors' Shareholdings The Company has today been informed that the following Directors have...
RNS Number:1872Q Metalrax Group PLC 25 September 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company METALRAX GROUP PLC 2) Name of shareholder having a...
RNS Number:0393Q Metalrax Group PLC 23 September 2003 METALRAX GROUP PLC RESULTS FOR THE HALF YEAR TO 30TH JUNE 2003 Increased profitability in first half "We are in a strong...
RNS Number:3530P Metalrax Group PLC 03 September 2003 Metalrax Group PLC (the "Company") Board Appointment & Notice of Results Board Appointment The Company is pleased to announce...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions